Estrogen Therapeutics: Global Markets to 2022 - Analysis on Key Players Abbott, Bayer, Novartis, Novo Nordisk, and Pfizer - ResearchAndMarkets.com

August 20, 2018

DUBLIN--(BUSINESS WIRE)--Aug 20, 2018--The “Global Estrogen Therapeutics Market 2018-2022” report has been added to ResearchAndMarkets.com’s offering.

The Global Estrogen Therapeutics Market is forecast to grow at a CAGR of 2.33% during the period 2018-2022.

The report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

One trend affecting this market is the development of innovative estrogen delivery systems New drug delivery systems such as transdermal drug delivery has gained popularity in the global estrogen therapeutics market. New drug delivery systems offer great flexibility, as these authorize localized treatment of specific tissues and controlled release methods for systematic delivery.

According to the report, one driver influencing this market is the increasing awareness about treatment of menopausal symptoms. The awareness about the negative impact of menopausal symptoms on the quality of life varies widely between countries and societies. In developed countries, such as the US, Canada, and Japan, and countries in Europe, the knowledge regarding occurrence and impact of menopausal symptoms and their treatment is widespread due to public literacy and government health programs.

Further, the report states that one challenge affecting this market is the health risks associated with estrogen therapy. There are some major side effects and risks associated with estrogen therapeutics and HRTs, which discourage their utilization among end consumers, thereby posing a challenge for the growth of the market.

Key Vendors

Abbott Bayer Novartis Novo Nordisk Pfizer

Key Topics Covered

1. Executive Summary

2. Scope of the Report

3. Research Methodology

4. Market Landscape

5. Market Sizing

6. Five Forces Analysis

7. Market Segmentation by Product

8. Customer Landscape

9. Market Segmentation by Estrogen Type

10. Regional Landscape

11. Decision Framework

12. Drivers and Challenges

13. Market Trends

14. Vendor Landscape

15. Vendor Analysis

For more information about this report visit https://www.researchandmarkets.com/research/gxw573/estrogen?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180820005194/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Endocrine and Metabolic Disorders Drugs



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 08/20/2018 04:35 AM/DISC: 08/20/2018 04:36 AM


Update hourly